Home › Cancer (all types) › Vermont › Burlington
Cancer (all types) clinical trials in Burlington, VT
6 studies for Cancer (all types) are looking for participants at sites in and around Burlington (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
RecruitingPhase 3
- The University of Vermont Medical Center Inc., Burlington
Project: Every Child for Younger Patients With Cancer
RecruitingObservational study
- University of Vermont and State Agricultural College, Burlington
Expanding the Support of Family Caregivers of Diverse Patients With Cancer and Diabetes
RecruitingHealthy volunteers welcome
- University of Vermont Cancer Center, Burlington
Care Coordination Educational Intervention Study for Patients From Rural Areas With Early Stage Cancer
Recruiting
- University of Vermont Cancer Center, Burlington
DOAC - Dosing Options in AntiCoagulation Prophylaxis
RecruitingPhase 3
- University of Vermont Medical Center, Burlington
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
Recruiting
- University of Vermont Medical Center, Burlington
- University of Vermount and Sate Agricultural College, Burlington
About Cancer (all types)
If you or someone you love has been diagnosed with cancer, learn about diagnosis, treatment, risk factors, coping and much more.
More about Cancer (all types) on MedlinePlus
Cancer (all types) trials in other cities
- Houston, TX122 studies
- New York City, NY110 studies
- Boston, MA86 studies
- Los Angeles, CA73 studies
- Nashville, TN65 studies
- Washington, DC60 studies
- Philadelphia, PA60 studies
- Durham, NC59 studies
- Chicago, IL52 studies
- Seattle, WA50 studies
- Atlanta, GA50 studies
- Arlington, VA48 studies
Other studies in Burlington
- Heart Failure8 studies
- Acute Myeloid Leukemia7 studies
- COPD5 studies
- Breast Cancer5 studies
- Parkinson's Disease4 studies
- Cystic Fibrosis4 studies
- Prostate Cancer4 studies
- Lung Cancer4 studies
- Leukemia4 studies
- Metastatic Cancer4 studies
- Non-Small Cell Lung Cancer4 studies
- Lung Diseases4 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.